Huw M. Nash, COO & CBO at Stoke Therapeutics, Inc. (STOK), sold 50,000 shares at $60.00 ($3.0M) on 2020-12-17, disclosed to the SEC on 2020-12-18.
Open-market sale of $3.0M STOK by COO & CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.00 | 41,985 | $2.5M | 84.0% |
| 2 | $60.00 | 8,015 | $481K | 16.0% |
| Total | $60.00 avg | 50,000 | $3.0M | 100% |
| Filing → |
| STOK | SELL | 2024-04-03 | $1.6M | — | Filing → |
| STOK | SELL | 2024-03-19 | $25K | — | Filing → |
| STOK | SELL | 2022-01-05 | $88K | — | Filing → |